fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
PIPERILATE ETHOBROMIDE |
Vascular Endothelinal Growth Factor (VEGF) |
-19% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 2 |
BUFLOMEDIL |
Chemokine CCR2B |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
PIPERILATE ETHOBROMIDE |
Phosphodiesterase PDE5 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
PIPERILATE ETHOBROMIDE |
Phosphodiesterase PDE5 |
-19% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
TEICOPLANIN |
beta-Lactamase |
-19% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
VINBLASTINE |
Protein Serine/Threonine Kinase, p38alpha |
-19% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
VINBLASTINE |
Protein Serine/Threonine Kinase, p38alpha |
-19% |
NoneNone |
NoneNone |
View
|
A3 adenosine receptor |
DACTINOMYCIN |
Adenosine A3 |
-19% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
CLOSANTEL |
Purinergic P2X |
-19% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Cannabinoid CB1 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4A, cAMP specific |
DIDANOSINE |
Phosphodiesterase PDE4 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4C, cAMP-specific |
DIDANOSINE |
Phosphodiesterase PDE4 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4D |
DIDANOSINE |
Phosphodiesterase PDE4 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4B, cAMP specific |
DIDANOSINE |
Phosphodiesterase PDE4 |
-19% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
TRICHLOROACETIC ACID |
HMG-CoA Reductase |
-19% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
TRICHLOROACETIC ACID |
HMG-CoA Reductase |
-19% |
NoneNone |
NoneNone |
View
|
nuclear receptor subfamily 3, group C, member 1 |
BROMOBENZENE |
Glucocorticoid |
-19% |
NoneNone |
NoneNone |
View
|
nuclear receptor subfamily 3, group C, member 1 |
BETA-NAPHTHOFLAVONE |
Glucocorticoid |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
HEXACHLOROPHENE |
Cyclooxygenase COX-1 |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
HEXACHLOROPHENE |
Cyclooxygenase COX-1 |
-19% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
BROMOBENZENE |
Chemokine CCR5 |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
ZINC CHLORIDE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
ZINC CHLORIDE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
BUSULFAN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
POLYVINYL ALCOHOL |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
POLYVINYL ALCOHOL |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
androgen receptor |
PRIMAQUINE |
Testosterone |
-20% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
PROBUCOL |
Histamine H2 |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
PROBUCOL |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
CARMOFUR |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, alpha polypeptide |
PRIMAQUINE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, alpha polypeptide |
PRIMAQUINE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, beta polypeptide |
PRIMAQUINE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
ARTEMETHER |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
ARTEMETHER |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4A, cAMP specific |
QUINACRINE |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4C, cAMP-specific |
QUINACRINE |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4D |
QUINACRINE |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4B, cAMP specific |
QUINACRINE |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
QUINACRINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
QUINACRINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
PYRAZINAMIDE |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
ROTENONE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
RISPERIDONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
RISPERIDONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
cholecystokinin A receptor |
ITRACONAZOLE |
Cholecystokinin CCKA |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
AZLOCILLIN |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
AZLOCILLIN |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
DEXKETOPROFEN |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
DEXKETOPROFEN |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
DEXKETOPROFEN |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
DEXKETOPROFEN |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
DEXKETOPROFEN |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
DEXKETOPROFEN |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
PROPYLTHIOURACIL |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
PROPYLTHIOURACIL |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
PROPYLTHIOURACIL |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
PROPYLTHIOURACIL |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
endothelin receptor type A |
LEUCOVORIN |
Endothelin ETA |
-20% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2A (inducible, hepatocytes) |
N,N'-DIPHENYL-P-PHENYLENEDIAMINE |
Nitric Oxide Synthase, Inducible (iNOS) |
-20% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2, inducible |
N,N'-DIPHENYL-P-PHENYLENEDIAMINE |
Nitric Oxide Synthase, Inducible (iNOS) |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
PROPYLTHIOURACIL |
Adrenergic alpha2B |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
PROPYLTHIOURACIL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
GLIMEPIRIDE |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
ANTIMYCIN A |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 1 (interstitial collagenase) |
ANTIMYCIN A |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
ANTIMYCIN A |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
ANTIMYCIN A |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
ANTIMYCIN A |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
melanocortin 5 receptor |
CICLOPIROX |
Melanocortin MC5 |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
CHOLECALCIFEROL |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
CHOLECALCIFEROL |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
HALOPROGIN |
Chemokine CXCR2 (IL-8B) |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
CICLOPIROX |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
CHOLECALCIFEROL |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
CHOLECALCIFEROL |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
TRIACETIN |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
TRIACETIN |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
HALOPROGIN |
Chemokine CCR4 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
HALOPROGIN |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
HALOPROGIN |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
HOMATROPINE HYDROBROMIDE |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
DISULFIRAM |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
DISULFIRAM |
Adenosine A1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
TRIACETIN |
Adrenergic alpha1A |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
ALOSETRON |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
ALOSETRON |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
DISULFIRAM |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
DISULFIRAM |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
DISULFIRAM |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
CICLOPIROX |
Chemokine CXCR2 (IL-8B) |
-20% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
HYDROCHLOROTHIAZIDE |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
HYDROCHLOROTHIAZIDE |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
EMETINE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
EMETINE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
TRIHEXYPHENIDYL |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
A3 adenosine receptor |
TRIOXSALEN |
Adenosine A3 |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
ANTIMYCIN A |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
endothelin receptor type A |
CICLOPIROX |
Endothelin ETA |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 1 (interstitial collagenase) |
TROGLITAZONE |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
CHOLECALCIFEROL |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
DISULFIRAM |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
DISULFIRAM |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
DISULFIRAM |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
TRIOXSALEN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TRIOXSALEN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
TROGLITAZONE |
Muscarinic M2 |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
TROGLITAZONE |
Chemokine CXCR2 (IL-8B) |
-20% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
NOVARTIS P-38 INHIBITOR |
Progesterone |
-20% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
NOVARTIS P-38 INHIBITOR |
Progesterone |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
PRIMAQUINE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
PROBUCOL |
Muscarinic M2 |
-20% |
NoneNone |
NoneNone |
View
|
melanocortin 5 receptor |
PROBUCOL |
Melanocortin MC5 |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
PARTHENOLIDE |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
PRIMAQUINE |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
PROBUCOL |
Muscarinic M3 |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
POLYVINYLPYRROLIDONE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
POLYVINYLPYRROLIDONE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
BUSULFAN |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
BUSULFAN |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
BUSULFAN |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
BUSULFAN |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
PRAMOXINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
PRAMOXINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
PRAMOXINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
PRAMOXINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
PHENYTOIN |
Adrenergic alpha1A |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
PHENYTOIN |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
PRAMOXINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
PRAMOXINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|